Works matching IS 21989788 AND DT 2024 AND VI 11 AND IP 3
Results: 18
The Association Between Deep Vein Thrombosis, Pulmonary Embolism, and Janus Kinase Inhibitors: Reporting Status and Signal Detection in the Japanese Adverse Drug Event Report Database.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 369, doi. 10.1007/s40801-024-00447-w
- By:
- Publication type:
- Article
Prescribing Cascades of Loop Diuretics and Anti-vertigo Drugs Following Treatment with Gabapentinoids and Benzodiazepines: Prescription Sequence Symmetry Analysis of a Large-Scale Claims Database Including Japanese Older Adults.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 529, doi. 10.1007/s40801-024-00446-x
- By:
- Publication type:
- Article
Impact of Third-Generation Antiseizure Medications on People with Epilepsy in a Low-Income Population: The Brivaracetam Experience in a Real-World Study.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 477, doi. 10.1007/s40801-024-00445-y
- By:
- Publication type:
- Article
Enhancing Outcomes in Chronic Fibrotic Interstitial Lung Disease Through Aggressive Management of Nintedanib-Induced Adverse Drug Reactions: A Retrospective Analysis.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 521, doi. 10.1007/s40801-024-00443-0
- By:
- Publication type:
- Article
Disease Stage and Motor Fluctuation Duration Predict Drug Tolerability: A Real-Life, Prospective Italian Multicenter Study on the Use of Opicapone in Parkinson's Disease.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 361, doi. 10.1007/s40801-024-00442-1
- By:
- Publication type:
- Article
Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 425, doi. 10.1007/s40801-024-00440-3
- By:
- Publication type:
- Article
Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 451, doi. 10.1007/s40801-024-00439-w
- By:
- Publication type:
- Article
Real-world Outcomes of Dual HER2 Blockade Therapy in Metastatic HER2-Positive Breast Cancer: from Induction to Maintenance.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 413, doi. 10.1007/s40801-024-00438-x
- By:
- Publication type:
- Article
Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 389, doi. 10.1007/s40801-024-00437-y
- By:
- Publication type:
- Article
Exploring the Association Between Heart Rate Control and Rehospitalization: A Real-World Analysis of Patients Hospitalized with Heart Failure with Reduced Ejection Fraction.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 501, doi. 10.1007/s40801-024-00436-z
- By:
- Publication type:
- Article
Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 377, doi. 10.1007/s40801-024-00435-0
- By:
- Publication type:
- Article
The Clinical Course of Bowel Urgency Severity Among Patients with Inflammatory Bowel Disease—A Real-World Study.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 403, doi. 10.1007/s40801-024-00434-1
- By:
- Publication type:
- Article
Falls and Fractures among Nursing Home Residents Treated with Pimavanserin versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson's Disease Psychosis.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 441, doi. 10.1007/s40801-024-00433-2
- By:
- Publication type:
- Article
Association of Drug–Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 345, doi. 10.1007/s40801-024-00432-3
- By:
- Publication type:
- Article
PCSK9 Inhibitors and Infection-Related Adverse Events: A Pharmacovigilance Study Using the World Health Organization VigiBase.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 465, doi. 10.1007/s40801-024-00430-5
- By:
- Publication type:
- Article
Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 487, doi. 10.1007/s40801-024-00428-z
- By:
- Publication type:
- Article
Real-World Amount of Clotting Factor Products and Non-Factor Products Dispensed and Annual Medical Expenditures for Japanese Patients with Haemophilia A.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 541, doi. 10.1007/s40801-024-00420-7
- By:
- Publication type:
- Article
The Association Between Antidepressant Use and Drug-Induced Liver Injury: A Nationwide, Population-Based Case–Control Study in Taiwan.
- Published in:
- Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 513, doi. 10.1007/s40801-024-00419-0
- By:
- Publication type:
- Article